| Kristie A Baker, MD | |
|
201 Nw R D Mize Rd Ste 206, Blue Springs, MO 64014-2513 | |
| (816) 655-5403 | |
| (816) 655-5257 |
| Full Name | Kristie A Baker |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 201 Nw R D Mize Rd Ste 206, Blue Springs, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124051941 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centerpoint Medical Center | Independence, MO | Hospital |
| Cass Regional Medical Center | Harrisonville, MO | Hospital |
| Lafayette Regional Health Center | Lexington, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pandc Healthcare Llc | 3779861109 | 43 |
| Cass Regional Medical Center | 7517853781 | 49 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | Midwest Division - Lrhc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639362460 PECOS PAC ID: 0941119150 Enrollment ID: O20031105000738 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | Cass Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477535326 PECOS PAC ID: 7517853781 Enrollment ID: O20040225000028 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | Ray County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245220052 PECOS PAC ID: 4688560634 Enrollment ID: O20040225001164 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | Ray County Memorial Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1245220052 PECOS PAC ID: 4688560634 Enrollment ID: O20081014000195 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | Inpatient Consultants Of Kansas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861795635 PECOS PAC ID: 9335329556 Enrollment ID: O20110204000829 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | Prime Healthcare Kansas City - Physician Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427449487 PECOS PAC ID: 7315267325 Enrollment ID: O20150514001835 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | Ipc Pac Healthcare Services Of Missouri Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326497587 PECOS PAC ID: 4587950589 Enrollment ID: O20160830002898 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | P&c Healthcare Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124575923 PECOS PAC ID: 3779861109 Enrollment ID: O20170302001808 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Entity Name | Nv Pacs 2 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427534809 PECOS PAC ID: 0941550578 Enrollment ID: O20210812000487 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristie A Baker, MD 201 Nw R D Mize Rd Ste 206, Blue Springs, MO 64014-2513 Ph: (816) 655-5403 | Kristie A Baker, MD 201 Nw R D Mize Rd Ste 206, Blue Springs, MO 64014-2513 Ph: (816) 655-5403 |
News Archive
In a BusinessDay opinion piece, Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria Michel Kazatchkine reflects on the organization's progress and impact on global health outcomes since its creation in 2002, as detailed in the organizations' 2010 annual report. Kazatchkine writes, 2010 "will be a decisive year; the world will be reviewing progress on the millennium goals. But this is also the year of the fund's replenishment. The results of that will decide where the world will be in 2015 with regard to the millennium goals."
A team in Australia has reviewed scientific evidence from the past 30 years to investigate the therapeutic effects of medicinal cannabinoids on mental health.
A new patent covering tumor suppression technologies, including the company's lead product candidate Oncoprex, was recently awarded to The University of Texas System by the Japan Patent Office. Patent number 4813746 pertains to the discovery that chromosome 3p21.3 genes act as cancer suppressors.
With so many sunscreen options on the market, it can be confusing to know which ones offer the best protection. A new study further emphasizes the importance of selecting a broad-spectrum sunscreen to protect the skin against skin cancer and early aging.
During the decade since the advent of highly active antiretroviral therapy (HAART), or 1996-2006, mortality among people living with HIV/AIDS (PLWHA) sharply decreased in the United States. So, too, did the percentages of PLWHA deaths attributable to AIDS-defining illnesses, just as there was a marked increase in the percentage of deaths attributable to heart, kidney, and liver disease.
› Verified 9 days ago
Michael Joseph Liston, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 Nw R D Mize Rd, Suite 200, Blue Springs, MO 64014 Phone: 816-220-1117 Fax: 816-228-2053 | |
Richard Tam Chung, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 500 Nw Vesper St, Blue Springs, MO 64014 Phone: 816-229-9411 Fax: 816-229-9411 | |
Dr. William F Sudholt, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Nw R D Mize Rd Ste 206, Blue Springs, MO 64014 Phone: 816-655-5403 Fax: 816-655-5257 | |
John Mcgarry Holkins, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 203 Nw Rd Mize Rd Ste 200, Blue Springs, MO 64014 Phone: 816-220-1117 Fax: 816-228-2053 | |
Corinne Sundar Rao, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Nw R D Mize Rd Ste 206, Blue Springs, MO 64014 Phone: 816-655-5403 Fax: 816-655-5257 | |
Dr. Sherry Wei Yang, M.D., PH.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Nw R D Mize Rd Ste 206, Blue Springs, MO 64014 Phone: 816-655-5403 Fax: 816-655-5257 |